Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glucagon-like peptide 1 receptor (GLP1R) haplotypes correlate with altered response to multiple antipsychotics in the CATIE trial.

Schizophrenia research - 1 Dec 2014

Ramsey Timothy L, Brennan Mark D

Abstract excerpt

Glucagon-like peptide 1 receptor (GLP1R) signaling has been shown to have antipsychotic properties in animal models and to impact glucose-dependent insulin release, satiety, memory, and learning in man. Previous work has shown that two coding mutations (rs6923761 and rs1042044) are associated with altered insulin release and cortisol levels. We identified four frequently occurring haplotypes in Caucasians,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Benzodiazepines

Share to Biomarkers, Pharmacological

Share to Glucagon-Like Peptide-1 Receptor

Share to Olanzapine

Share to Receptors, Glucagon

Share to Risperidone

Share to Thiazoles

Share to Weight Gain

Source

Open in PubMed Open full text

Identifiers

PMID: 25449714
DOI: 10.1016/j.schres.2014.09.038
PMCID: PMC4258179

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glucagon-like peptide 1 receptor (GLP1R) haplotypes correlate with altered response to multiple antipsychotics in the CATIE trial.PMID 25449714Read ↗

Evidence for a SULT4A1 haplotype correlating with baseline psychopathology and atypical antipsychotic response.Semantic proximity Read ↗

SULT4A1 haplotype: conflicting results on its role as a biomarker of antipsychotic response.Semantic proximity Read ↗

Genome-wide association study on antipsychotic-induced weight gain in the CATIE sample.Semantic proximity Read ↗

Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.Semantic proximity Read ↗

Genetic variation in the GCG and in the GLP1R genes and antipsychotic-induced weight gain.Semantic proximity Read ↗

A meta-analysis of potential genetic factors associated with antipsychotic-induced weight gain in adults with severe mental illness.Semantic proximity Read ↗

Impact of Glucagon-like Peptide-1 Receptor Agonists on Mental Illness: Evidence from a Mendelian Randomization StudySemantic proximity Read ↗

Antipsychotic Use in Bipolar Disorder: Clinical and Genomic Correlates– A Mayo Clinic Bipolar Disorder Biobank StudySemantic proximity Read ↗

GLP1R gene expression is associated with metabolic and mental health effects in a phenome-wide drug repurposing and safety analysisSemantic proximity Read ↗

Exploring glucagon-like peptide-1 receptor agonists as potential disease-modifying agent in psychiatric and neurodevelopmental conditions: evidence from a drug target Mendelian randomizationSemantic proximity Read ↗

Physiogenomic comparison of weight profiles of olanzapine- and risperidone-treated patients.Semantic proximity Read ↗

Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.